"Cleveland Clinic is one of the largest and most respected hospitals in the country. Our mission is to provide better care of the sick, investigation into their problems, and further education of those who serve. Learn more about our leadership, vision, values and model of healthcare. Every life deserves world class care. Call or visit our website for appointment information."

During the past decade, Cleveland Clinic Cancer Center Mansfield conducted 69 clinical trials. In the 10-year time frame, 69 clinical trials started and 25 clinical trials were completed, i.e. on average, 36.2% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 22 clinical trials were completed. i.e. 78.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cleveland Clinic Cancer Center Mansfield" #1 sponsor was "National Cancer Institute (NCI)" with 33 trials, followed by "SWOG Cancer Research Network" with 24 trials sponsored, "NRG Oncology" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored and "AVEO Pharmaceuticals, Inc." with 7 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cleveland Clinic Cancer Center Mansfield" #1 collaborator was "National Cancer Institute (NCI)" with 45 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Cleveland Clinic Cancer Center Mansfield" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Lung Cancer AJCC v8" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Invasive Breast Carcinoma" (5 trials) and "Recurrent Breast Carcinoma" (5 trials). Many other conditions were trialed in "Cleveland Clinic Cancer Center Mansfield" in a lesser frequency.

Most popular intervention types in "Cleveland Clinic Cancer Center Mansfield" are "Drug" (70 trials), "Other" (50 trials), "Biological" (32 trials), "Radiation" (19 trials) and "Procedure" (14 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (25 trials), "Quality-of-Life Assessment" (23 trials), "Questionnaire Administration" (13 trials), "Biospecimen Collection" (11 trials) and "Cisplatin" (11 trials). Other intervention names were less common.

The vast majority of trials in "Cleveland Clinic Cancer Center Mansfield" are 70 trials for "All" genders, 8 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Cleveland Clinic Cancer Center Mansfield". undefined are not yet recruiting, 29 are recruiting, 33 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Cleveland Clinic Cancer Center Mansfield, 4 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Cleveland Clinic Cancer Center Mansfield, 2 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 58 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".